{"Symbol": "RVTY", "AssetType": "Common Stock", "Name": "Revvity Inc.", "Description": "Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.", "CIK": "31791", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "LABORATORY ANALYTICAL INSTRUMENTS", "Address": "940 WINTER STREET, WALTHAM, MA, US", "OfficialSite": "https://www.revvity.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "11093172000", "EBITDA": "837635000", "PERatio": "40.14", "PEGRatio": "0.654", "BookValue": "63.55", "DividendPerShare": "0.28", "DividendYield": "0.003", "EPS": "2.3", "RevenuePerShareTTM": "22.44", "ProfitMargin": "0.0981", "OperatingMarginTTM": "0.187", "ReturnOnAssetsTTM": "0.0197", "ReturnOnEquityTTM": "0.0364", "RevenueTTM": "2755026000", "GrossProfitTTM": "1537659000", "DilutedEPSTTM": "2.3", "QuarterlyEarningsGrowthYOY": "0.219", "QuarterlyRevenueGrowthYOY": "0.048", "AnalystTargetPrice": "132.55", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "9", "AnalystRatingHold": "7", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "40.14", "ForwardPE": "18.66", "PriceToSalesRatioTTM": "4.027", "PriceToBookRatio": "1.447", "EVToRevenue": "4.811", "EVToEBITDA": "15.78", "Beta": "1.07", "52WeekHigh": "129.33", "52WeekLow": "88.53", "50DayMovingAverage": "107.02", "200DayMovingAverage": "115.52", "SharesOutstanding": "120147000", "DividendDate": "2025-05-09", "ExDividendDate": "2025-04-17"}